Blog
RSS FeedPosted by Michael Wonder on 06 Jun 2017
Workshop: addressing unmet needs of children with pulmonary arterial hypertension
6 June 2017 - The EMA, the United States FDA and Health Canada are co-organising a workshop to discuss the ...
Posted by Michael Wonder on 05 Jun 2017
Prima’s trial backs safety of metastatic breast cancer drug
5 June 2017 - The Lucy Turnbull-chaired biotech Prima Biomed has revealed new data that backs the safety of its ...
Posted by Michael Wonder on 31 May 2017
New action plan to support SMEs as drivers of pharmaceutical innovation
31 May 2017 - 16 actions identified for implementation in 2017-2020. ...
Posted by Michael Wonder on 31 May 2017
South Australia slashes pathology, medical science jobs
31 May 2017 - Medical unions say timely patient treatments and diagnoses could be at risk after the South Australian ...
Posted by Michael Wonder on 25 May 2017
Medical research reforms to improve our future health
25 May 2017 - The Australian Government provides more than $800 million through the National Health and Medical Research Council each ...
Posted by Michael Wonder on 25 May 2017
Strength in clinical trials set to grow with funding boost
25 May 2017 - Australia’s world-class clinical trial capabilities are set to grow, with a $33 million funding boost announced ...
Posted by Michael Wonder on 22 May 2017
Pharma exec says industry must get fair about pricing new drugs
19 May 2017 - The head of Regeneron Pharmaceuticals is warning the controversy surrounding drug prices could cripple the country’s ...
Posted by Michael Wonder on 17 May 2017
How patients are changing clinical trials
17 May 2017 - In September, the FDA approved a controversial drug to treat Duchenne muscular dystrophy, a rare but deadly ...
Posted by Michael Wonder on 10 May 2017
MTPConnect welcomes 2017 Budget: investment in MTP research translation and commercialisation
10 May 2017 - MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has ...
Posted by Michael Wonder on 09 May 2017
Strategic Agreement between the Innovative pharmaceutical industry and government delivers certainty for industry, savings to taxpayers and benefits to patients
9 May 2017 - Medicines Australia has signed a strategic agreement with the Australian Government that will support ongoing access ...
Posted by Michael Wonder on 04 May 2017
How drugmakers face global push-back on high prices
4 May 2017 - Pharmaceutical companies are under fire around the world as a wave of new treatments for cancer ...
Posted by Michael Wonder on 04 May 2017
The failure of solanezumab — How the FDA saved taxpayers billions
3 May 2017 - The failure of solanezumab offers a window into the U.S. drug regulatory system, particularly in the context ...
Posted by Michael Wonder on 02 May 2017
Survey shows biotech industry buoyant, but fearing imminent policy change
2 May 2017 - AusBiotech’s annual survey of biotechnology industry CEOs shows the strongest year on record, but the result ...
Posted by Michael Wonder on 27 Apr 2017
New Government ‘must be more ambitious in securing a world-class NHS’, says UK pharmaceutical industry
27 April 2017 - The new Government must be more ambitious in securing a world-class NHS for patients and improve ...
Posted by Michael Wonder on 10 Apr 2017
QUT, MTPConnect and industry partnership will help to ensure Australia stays globally competitive
10 April 2017 - Medicines Australia warmly welcomes the commencement of The Bridge Program – an initiative of a consortium ...